Evidence map›Paper›PMID 37575880›Full record

ArticleNorth American Spine Society journal2023

Multidisciplinary management of recurrent synovial sarcoma of the chest wall.

Santiago A Endara, Juan S De la Torre, Fernando J Terán, Juan Pablo Alarcón, Carla E Tovar

Open access · goldAbstract readCase Reports
In one paragraph

Article in North American Spine Society journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Santiago A EndaraCardiovascular and Thoracic surgeon, Hospital Metropolitano, Quito, Ecuador.
Juan S De la TorreSpine Surgeon, Hospital Metropolitano, Quito, Ecuador.
Fernando J TeránOrthopedic surgery senior resident, Universidad Internacional del Ecuador, Quito, Ecuador.
Juan Pablo AlarcónGeneral Surgery resident, Universidad Internacional del Ecuador, Quito, Ecuador.
Carla E TovarOncologist surgeon, Hospital Metropolitano. Quito, Ecuador.
Universidad Internacional del Ecuador · ECHospital Metropolitano · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Synovial sarcoma (SS) is part of soft tissue sarcomas (STS). An incidence between 5% to 10% is estimated. The origin is mesenchymal mainly affecting the extremities. Being even rarer at the chest level and vertebral body, representing around 1%. Histologically, it consists of 3 variants: monophasic, biphasic, and poorly differentiated. Surgical resection is a priority when it comes to multidisciplinary management. The prognosis of patients with SS over the years has improved markedly. Purpose: Understand and evaluate the multidisciplinary management of SS considering that the SS has a lowe prevalence and highly malignancy. Study Design: We present a case of a 31-year-old male who has a history of monophasic synovial sarcoma diagnosed in 2019 and underwent surgery. Patient came back after two years without symptoms and posterior to a control MRI we observed a local recurrence of SS. Methods: The literature was reviewed with a focus on best clinical and surgical strategy for recurrence of SS. Results: The patient recovered well with return to his normal daily activities. The review of the literature shows us the importance of the multidisciplinary management for the optimal clinical and surgical approach of SS recurrence. Conclusions: SS represents a unique variant of STS, with malignant and metastatic potential. Being a rare pathology, an adequate multidisciplinary management is essential when providing optimal care for the patient.

Indexed as

Adjuvant therapiesLocal recurrenceMultidisciplinary managementSynovial sarcoma

Identifiers

PMID37575880
PMCPMC10415753
OpenAlexW4384918229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.